Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.54 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.53 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
| ▸ | RXRB | P28702 | 2/20 | 0.50 |
| ▸ | RXRG | P48443 | 2/20 | 0.50 |
| ▸ | LSS | P48449 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7159528 | 0.98 | ALDH1A1 (0.57) | ALDH1A1TSHRHRH3MEP1BALDH2 | |
| Hydrochloric Acid SCHEMBL5065552 | 0.98 | ALDH1A1 (0.57) | ALDH1A1TSHRHRH3MEP1BALDH2 | |
| SCHEMBL13799721 | 0.88 | ALDH1A1 (0.52) | ALDH1A1TSHRHRH3MEP1BALDH2 | |
| Trolamine SCHEMBL5693934 | 0.88 | MEP1B (0.47) | ALDH1A1TSHRHRH3MEP1BALDH2 | |
| SCHEMBL8781885 | 0.85 | ALDH1A1 (0.57) | ALDH1A1TSHRMEP1BALDH2TP53 | |
| SCHEMBL25137173 | 0.84 | HRH3 (0.56) | ALDH1A1TSHRHRH3TAAR1LSS | |
| SCHEMBL11806886 | 0.83 | LTA4H (0.56) | ALDH1A1TSHRMEP1BALDH2TP53 | |
| SCHEMBL14487913 | 0.83 | ACHE (0.57) | ALDH1A1MEP1BALDH2KMT2ARXRA | |
| SCHEMBL12734915 | 0.83 | PYCR1 (0.62) | ALDH1A1TSHRHRH3TAAR1KMT2A | |
| SCHEMBL14419055 | 0.82 | ALDH1A1 (0.59) | ALDH1A1TSHRHRH3TAAR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432425-A | Demulsifier special for desalting heavy fuel oil for gas turbine and preparation method thereof | 佛山市天辰洁能环保技术有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118388818-A | Nanometer packaging material for fruit preservation and preparation method thereof | 无锡市阳山镇阳阳水蜜桃专业合作社 | 2024-07-26 | — | — | CN | claimed |
| EP-3707140-B1 | PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONISTS | COUNCIL SCIENT IND RES (IN) | 2021-10-13 | — | — | EP | claimed |
| US-20200347062-A1 | PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-11-05 | — | — | US | claimed |
| US-8367745-B2 | Includes alkaline earth metal oxide as acidity neutralization stabilizer; quick setting, mechanical strength; repairing prosthesis | GC CORPORATION (JP) | 2013-02-05 | — | — | US | claimed |
| JP-3099094-A | — | — | None | — | — | JP | disclosed |
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | ROTTAPHARM BIOTECH S.R.L. (IT) | 2025-12-30 | — | — | US | disclosed |
| US-12383560-B2 | Compounds and uses thereof | FOGHORN THERAPEUTICS INC. (US) | 2025-08-12 | — | — | US | disclosed |
| EP-4551568-A1 | TRPV2 CHANNEL BLOCKERS AND USE THEREOF | Ichilov Tech Ltd. (IL) | 2025-05-14 | — | — | EP | disclosed |
| CN-119998259-A | Lipid structures and compositions comprising the same | 特恩生物技术公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4543847-A2 | LIPID STRUCTURES AND COMPOSITIONS COMPRISING SAME | Turn Biotechnologies, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119816492-A | TRPV2 channel blocker and use thereof | 伊契洛夫科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-5063257-A | DENTAL GLASS IONOMER CEMENT COMPOSITIONS | G-C DENTAL INDUSTRIAL CORP. (JP) | 1991-11-05 | — | — | US | disclosed |
| JP-H0399094-A | LIQUID CRYSTAL-NATURED ESTER FROM ORGANIC ACID AND TRITERPENE ALCOHOL | SHIRATORI SEIYAKU KK | 1991-04-24 | — | — | JP | disclosed |
| WO-1990008128-A1 | NOVEL PRODRUG DERIVATIVES OF BIOLOGICALLY ACTIVE AGENTS CONTAINING HYDROXYL GROUPS OR NH-ACIDIC GROUPS | BUNDGAARD HANS (DK) | 1990-07-26 | — | — | WO | disclosed |
| EP-0332647-A1 | NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Aktiebolaget Hässle (SE) | 1989-09-20 | — | — | EP | disclosed |
| EP-0279149-A2 | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | Aktiebolaget Hässle (SE) | 1988-08-24 | — | — | EP | disclosed |
| US-4751167-A | REDUCTION OF ADHESION OF MULTILAYER DEVICE UPON EXPOSURE TO LIGHT | KIMOTO & CO., LTD. (JP) | 1988-06-14 | — | — | US | disclosed |
| WO-1988003921-A1 | NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Aktiebolaget Hässle (SE) | 1988-06-02 | — | — | WO | disclosed |
| EP-0208404-A2 | Benzothiazine dioxide derivatives | PFIZER INC. (US) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | FYN, LCK, LYN | ALDH1A1 4279/4885TSHR 1595/4885HRH3 2608/4885 |
| US-12383560-B2 | Compounds and uses thereof | VHL, CLN6, TFEB | ALDH1A1 2571/4885TSHR 4351/4885HRH3 3347/4885 |
| US-20200347062-A1 | PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST | TLR9, TLR1, TLR7 | ALDH1A1 2999/4885TSHR 1354/4885HRH3 195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.